Full document - International Hospital Federation
Full document - International Hospital Federation
Full document - International Hospital Federation
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Innovation in clinical specialities: cardiovascular disease<br />
number of deaths postponed or prevented but did not alter the<br />
relative contribution of each risk factor (Table 5, columns 5 and 6).<br />
Thus, regardless of whether best, minimum or maximum<br />
estimates were considered, the most substantial contributions<br />
came from the changes in cholesterol, blood pressure and<br />
smoking (Table 5).<br />
Discussion<br />
Success in achieving the HP2010 targets could almost halve<br />
predicted CHD deaths in 2010, or indeed in 2015. Our findings are<br />
reassuringly consistent with earlier studies in the England, 23<br />
Scotland 22 and the USA 12 . In the United Kingdom, a modest<br />
reduction in mean population cholesterol level from 225 mg/dl to<br />
200 mg/dl could reduce CHD deaths by approximately half. 14,15,24 In<br />
contrast, a rather optimistic 25% reduction in the prevalence of<br />
obesity would probably prevent just 2% of CHD deaths. 15,24 A<br />
corresponding 25% reduction in the prevalence of inactivity might<br />
prevent 1% of CHD deaths. 15,29<br />
Although CHD death rates have been falling in the USA for four<br />
decades, they are now plateauing in young men and women. 2<br />
Recent declines in total cholesterol have been modest, blood<br />
pressure is now rising among women and obesity and diabetes are<br />
20 000<br />
0<br />
-20 000<br />
-40 000<br />
-60 000<br />
-80 000<br />
-100 000<br />
-120 000<br />
-140 000<br />
-160 000<br />
-180 000<br />
-5000<br />
-45 000<br />
-85 000<br />
-125 000<br />
-28 300<br />
-33 540<br />
C holes terol<br />
-103 080<br />
25-34<br />
355-300<br />
1525 2235<br />
-1525<br />
2190<br />
-48 635<br />
Systo lic B P<br />
-82 520<br />
35-44<br />
-4190<br />
-12 175<br />
Smoking<br />
-10 020 -6810<br />
-12 010<br />
-26 270<br />
-33 670<br />
-60 135<br />
IF Current trends continue to 2010<br />
IF Healthy People 2010 targets<br />
IF USA Low Risk stratum<br />
-20815<br />
45-54<br />
-45 770<br />
-1450<br />
IF Current trends continue to 2010<br />
IF Healthy People 2010 targets<br />
IF USA Low Risk stratum<br />
-43 615<br />
55-64<br />
-88 500<br />
8105<br />
BMI<br />
P hysical A ctivity<br />
-17 430<br />
-20 535<br />
-8775<br />
-52 300<br />
65-74<br />
-106 295<br />
15885<br />
rising steeply. Furthermore, population aging will increase the<br />
numbers of CHD deaths in that country and elsewhere. 30 There is<br />
no room for complacency. Continuation of recent risk factor trends<br />
should result in approximately 20 000 fewer coronary deaths in<br />
2010 than in 2000. This reflects some 50 000 fewer deaths<br />
expected from improvements in total cholesterol, smoking, physical<br />
activity and male blood pressure, but more than half of the gain is<br />
negated by approximately 30 000 additional deaths attributable to<br />
increases in rates of obesity and diabetes, plus systolic blood<br />
pressure increases among women. Increasing treatments could<br />
not compensate for these worsening risk factors. In 2000, barely<br />
40% of eligible patients received appropriate therapies. 10 Even<br />
raising this proportion to an optimistic 50% would only postpone<br />
approximately 60 000 additional deaths in 2010. 31<br />
Successfully achieving the specific risk factor reductions<br />
proposed in the HP2010 targets could prevent or postpone<br />
approximately 190 000 CHD deaths. This would potentially halve<br />
the mortality burden seen in 2000. The HP2010 objectives for<br />
cholesterol and physical activity remain potentially attainable.<br />
However, attaining the targets for obesity, diabetes and female<br />
blood pressure appear more challenging because of the need to<br />
actually reverse recent adverse trends. 3 Successfully reducing<br />
population risk factor levels to those already seen in<br />
the healthiest (lowrisk) stratum could result in<br />
approximately 370 000 fewer CHD deaths among<br />
people aged 25–84 years. This figure would represent<br />
a 96% decrease compared to the 2000 baseline of<br />
388 000 1,3 and is somewhat larger than the 85%<br />
reduction predicted by other studies. 24,25 Although<br />
probably an overestimate, the results for this third<br />
scenario show an aspirational ideal to highlight<br />
potential future gains. However, the “low-risk stratum”<br />
in the population of the USA remains frustratingly<br />
small, even when defined only by smoking, blood<br />
-71 860<br />
pressure and cholesterol: 6% in the 1970s 32 and,<br />
even now, only 7.5% among whites and 4% among<br />
African Americans. 33<br />
-43 900<br />
-11 840<br />
-61 790<br />
Diabetes<br />
Figure 1: Estimated reductions in coronary heart disease mortality in the United<br />
. States 2. Estimated of America reductions in 2010 under in coronary three different heart disease scenarios mortality in the United State<br />
75-84<br />
-119 705<br />
Figure 2: Estimated reductions in coronary heart disease mortality in the United<br />
States of America in 2010 by age group under three different scenarios<br />
Achieving risk factor reductions<br />
Although fashionable, screening and treating high-risk<br />
individuals would necessitate medicating 15% to<br />
25% of all adults. 34,35 Furthermore, the key goal is not<br />
intervention but sustained risk factor reductions. 35 The<br />
whole population approach described by Rose 13<br />
appears both more effective and cost-effective. 13–15<br />
Similar conclusions have been reported previously in<br />
Dutch, Finnish and American cohorts. 12,35<br />
Lowering cholesterol should therefore remain a<br />
priority in the USA, as it offers a potentially powerful<br />
1% mortality reduction for every 1 mg/dl decrease in<br />
total cholesterol. 6 Large cholesterol declines have<br />
already been achieved by comprehensive national<br />
policies elsewhere (-20% in Finland 18 and -15% in<br />
Mauritius 36 ). In contrast, in the USA between 1988<br />
and 2004 total cholesterol fell barely 3% in adults<br />
(from 206 to 201 mg/dl). 37 Furthermore, these levels<br />
remain well above the optimal, prompting recent<br />
national dietary policies to further reduce total<br />
cholesterol levels. 2,3,38<br />
<strong>Hospital</strong> and Healthcare Innovation Book 2009/2010 73